These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 29232958)

  • 1. ARCHITECT HIV Combo Ag/Ab and RealTime HIV-1 Assays Detect Diverse HIV Strains in Clinical Specimens.
    Rodgers MA; Vallari AS; Yamaguchi J; Holzmayer V; Harris B; Toure-Kane C; Mboup S; Badreddine S; McArthur C; Ndembi N; Mbanya D; Kaptue L; Cloherty G
    AIDS Res Hum Retroviruses; 2018 Mar; 34(3):314-318. PubMed ID: 29232958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ARCHITECT® HIV Ag/Ab Combo assay: correlation of HIV-1 p24 antigen sensitivity and RNA viral load using genetically diverse virus isolates.
    Brennan CA; Yamaguchi J; Vallari A; Swanson P; Hackett JR
    J Clin Virol; 2013 Jun; 57(2):169-72. PubMed ID: 23485348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Performance of an alternative HIV diagnostic algorithm using the ARCHITECT HIV Ag/Ab Combo assay and potential utility of sample-to-cutoff ratio to discriminate primary from established infection.
    Ramos EM; Harb S; Dragavon J; Swenson P; Stekler JD; Coombs RW
    J Clin Virol; 2013 Dec; 58 Suppl 1(0 1):e38-43. PubMed ID: 24029686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of early HIV infections using the fourth generation Abbott ARCHITECT HIV Ag/Ab Combo chemiluminescent microparticle immunoassay (CIA) in San Diego County.
    Manlutac AL; Giesick JS; McVay PA
    J Clin Virol; 2013 Dec; 58 Suppl 1():e44-7. PubMed ID: 24342477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Performance of the Alere Determine™ HIV-1/2 Ag/Ab Combo Rapid Test with specimens from HIV-1 seroconverters from the US and HIV-2 infected individuals from Ivory Coast.
    Masciotra S; Luo W; Youngpairoj AS; Kennedy MS; Wells S; Ambrose K; Sprinkle P; Owen SM
    J Clin Virol; 2013 Dec; 58 Suppl 1(Suppl 1):e54-8. PubMed ID: 23911678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative evaluation of three FDA-approved HIV Ag/Ab combination tests using a genetically diverse HIV panel and diagnostic specimens.
    Qiu X; Sokoll L; Yip P; Elliott DJ; Dua R; Mohr P; Wang XY; Spencer M; Swanson P; Dawson GJ; Hackett J
    J Clin Virol; 2017 Jul; 92():62-68. PubMed ID: 28535437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Field evaluation of the Abbott ARCHITECT HIV Ag/Ab Combo immunoassay.
    Kfutwah A; Lemée V; Ngono HV; De Oliveira F; Njouom R; Plantier JC
    J Clin Virol; 2013 Dec; 58 Suppl 1():e70-5. PubMed ID: 24342480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Performance comparison of the 4th generation Bio-Rad Laboratories GS HIV Combo Ag/Ab EIA on the EVOLIS™ automated system versus Abbott ARCHITECT HIV Ag/Ab Combo, Ortho Anti-HIV 1+2 EIA on Vitros ECi and Siemens HIV-1/O/2 enhanced on Advia Centaur.
    Mitchell EO; Stewart G; Bajzik O; Ferret M; Bentsen C; Shriver MK
    J Clin Virol; 2013 Dec; 58 Suppl 1():e79-84. PubMed ID: 24342482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of Detection Limits of Fourth- and Fifth-Generation Combination HIV Antigen-Antibody, p24 Antigen, and Viral Load Assays on Diverse HIV Isolates.
    Stone M; Bainbridge J; Sanchez AM; Keating SM; Pappas A; Rountree W; Todd C; Bakkour S; Manak M; Peel SA; Coombs RW; Ramos EM; Shriver MK; Contestable P; Nair SV; Wilson DH; Stengelin M; Murphy G; Hewlett I; Denny TN; Busch MP
    J Clin Microbiol; 2018 Aug; 56(8):. PubMed ID: 29793968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heterophilic interference in specimens yielding false-reactive results on the Abbott 4th generation ARCHITECT HIV Ag/Ab Combo assay.
    Lavoie S; Caswell D; Gill MJ; Kadkhoda K; Charlton CL; Levett PN; Hatchette T; Garceau R; Maregmen J; Mazzulli T; Needle R; Kadivar K; Kim J
    J Clin Virol; 2018 Jul; 104():23-28. PubMed ID: 29704735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Performance of the new HIV-1/2 diagnostic algorithm in Florida's public health testing population: a review of the first five months of utilization.
    Bennett B; Neumann D; Fordan S; Villaraza R; Crowe S; Gillis L
    J Clin Virol; 2013 Dec; 58 Suppl 1():e29-33. PubMed ID: 24342476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Performance evaluation of three automated human immunodeficiency virus antigen-antibody combination immunoassays.
    Kwon JA; Yoon SY; Lee CK; Lim CS; Lee KN; Sung HJ; Brennan CA; Devare SG
    J Virol Methods; 2006 Apr; 133(1):20-6. PubMed ID: 16313975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Performances of four fourth-generation human immunodeficiency virus-1 screening assays.
    Song EY; Hur M; Roh EY; Park MH; Moon HW; Yun YM
    J Med Virol; 2012 Dec; 84(12):1884-8. PubMed ID: 23080491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Performance evaluation of the FDA-approved Determine™ HIV-1/2 Ag/Ab Combo assay using plasma and whole blood specimens.
    Masciotra S; Luo W; Westheimer E; Cohen SE; Gay CL; Hall L; Pan Y; Peters PJ; Owen SM
    J Clin Virol; 2017 Jun; 91():95-100. PubMed ID: 28372891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Poor performance of the determine HIV-1/2 Ag/Ab combo fourth-generation rapid test for detection of acute infections in a National Household Survey in Swaziland.
    Duong YT; Mavengere Y; Patel H; Moore C; Manjengwa J; Sibandze D; Rasberry C; Mlambo C; Li Z; Emel L; Bock N; Moore J; Nkambule R; Justman J; Reed J; Bicego G; Ellenberger DL; Nkengasong JN; Parekh BS
    J Clin Microbiol; 2014 Oct; 52(10):3743-8. PubMed ID: 25122853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sample-to-cutoff ratios using Architect HIV Ag/Ab Combo: The influence with the results of supplemental tests and optimal cutoff value to predict HIV infection.
    Wang L; Wang JY; Tian XD; Ruan JX; Yu Y; Yan F
    J Clin Lab Anal; 2019 Jun; 33(5):e22866. PubMed ID: 30803030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid Testing Algorithm Performance in a Low-Prevalence Environment.
    Martin EG; Cornett J; Mohammed DY; Salaru G
    Sex Transm Dis; 2020 May; 47(5S Suppl 1):S35-S40. PubMed ID: 31977973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of acute HIV infection: a field evaluation of the determine® HIV-1/2 Ag/Ab combo test.
    Rosenberg NE; Kamanga G; Phiri S; Nsona D; Pettifor A; Rutstein SE; Kamwendo D; Hoffman IF; Keating M; Brown LB; Ndalama B; Fiscus SA; Congdon S; Cohen MS; Miller WC
    J Infect Dis; 2012 Feb; 205(4):528-34. PubMed ID: 22207651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the performance of the Abbott ARCHITECT HIV Ag/Ab Combo Assay.
    Chavez P; Wesolowski L; Patel P; Delaney K; Owen SM
    J Clin Virol; 2011 Dec; 52 Suppl 1():S51-5. PubMed ID: 21983253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Performance of serological and molecular tests within acute HIV infection.
    Fransen K; de Baetselier I; Rammutla E; Ahmed K; Owino F; Agingu W; Venter G; Deese J; Van Damme L; Crucitti T;
    J Clin Virol; 2017 Aug; 93():81-84. PubMed ID: 28351688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.